Skip to main content

Incorporating Patient Preferences and Quality of Life

  • Chapter
  • First Online:
Lentigo Maligna Melanoma

Abstract

In slowly progressive cancers such as lentigo maligna and lentigo maligna melanoma (LM/LMM), the optimal management may vary widely among different patients. Comorbidity and patient preference should be addressed when discussing treatment options, notably in the elderly population that is often affected, as most cases of LM/LMM are nonfatal. While health related quality of life has not been well-studied in regards to facial LM/LMM and its treatment, this area of research may lend important insights into optimizing disease management. An individualized plan accounting for patient comorbidities, social support, and aesthetic concerns should be developed using a model of shared decision-making.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Swetter SM, Boldrick JC, Jung SY, Egbert BM, Harvell JD. Increasing incidence of lentigo maligna melanoma subtypes: northern California and national trends 1990–2000. J Invest Dermatol. 2005;125(4):685–91.

    Article  CAS  PubMed  Google Scholar 

  2. Read WL, Tierney RM, Page NC, et al. Differential prognostic impact of comorbidity. J Clin Oncol. 2004;22(15):3099–103.

    Article  PubMed  Google Scholar 

  3. Lee EH, Brewer JD, MacFarlane DF. Optimizing informed decision making for basal cell carcinoma in patients 85 years or older. JAMA Dermatol. 2015;151(8):817–8.

    Article  PubMed  Google Scholar 

  4. Lee EH, Klassen AF, Lawson JL, Cano SJ, Scott AM, Pusic AL. Patient experiences and outcomes following facial skin cancer surgery: a qualitative study. Aust J Dermatol. 2016 Aug;57(3):100–4.

    Google Scholar 

  5. Schlesinger-Raab A, Schubert-Fritschle G, Hein R, et al. Quality of life in localised malignant melanoma. Ann Oncol. 2010;21(12):2428–35.

    Article  CAS  PubMed  Google Scholar 

  6. Kasparian NA, McLoone JK, Butow PN. Psychological responses and coping strategies among patients with malignant melanoma: a systematic review of the literature. Arch Dermatol. 2009;145(12):1415–27.

    Article  PubMed  Google Scholar 

  7. Cornish D, Holterhues C, van de Poll-Franse LV, Coebergh JW, Nijsten T. A systematic review of health-related quality of life in cutaneous melanoma. Ann Oncol. 2009;20 Suppl 6:vi51–8.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Karen L. Connolly MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Connolly, K.L., Lee, E.H. (2017). Incorporating Patient Preferences and Quality of Life. In: Nehal, K., Busam, K. (eds) Lentigo Maligna Melanoma. Springer, Cham. https://doi.org/10.1007/978-3-319-43787-3_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-43787-3_13

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-43785-9

  • Online ISBN: 978-3-319-43787-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics